Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Akron Biotech, a provider of cell culture products, has launched CryoSolve, a cGMP single-use cell cryopreservation media, containing DMSO USP/EP 55% w/v, Dextran-40 USP/EP 5% w/v and WFI, with a 10% final DMSO concentration.
Subscribe to our email newsletter
According to the company, CryoSolve contains all organic raw materials – serum-free/animal-free, packaged in single-use syringes filled with ready-for-use media. Syringes have Luer-lock tips to help ease the process, eliminate sharps, avoid cross contamination and streamline process steps, the company said. CryoSolve syringes contain 7ml ready-to-use media and are sold in kits of 25 syringes per kit.
Syringes are made of Type 1 borosilicate glass, USP Class VI, compatible with DMSO. All equipment used in the manufacturing passed compatibility studies and meets the requirements of low leachables/extractables, low toxicity and high purity, the company added.
Claudia Zylberberg, CEO and president of Akron Biotech, said: CryoSolve is made out of the same formula that has been widely used for decades for the cryopreservation of cells.
However, we have developed a product that is challenging the current standards by using only the highest quality raw materials, manufactured under cGMP, and packaged in a way that will better serve our clients. We expect the use of CryoSolve to become the best practice in the cryopreservation process.